These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25767302)

  • 21. Analysis of six SNPs of NAT2 in Ngawbe and Embera Amerindians of Panama and determination of the Embera acetylation phenotype using caffeine.
    Jorge-Nebert LF; Eichelbaum M; Griese EU; Inaba T; Arias TD
    Pharmacogenetics; 2002 Jan; 12(1):39-48. PubMed ID: 11773863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of NAT2 in immune system cells and the relation of NAT2 gene polymorphisms in the anti-tuberculosis therapy in Mexican mestizo population.
    Salazar-González R; Gómez R; Romano-Moreno S; Medellín-Garibay S; Núñez-Ruíz A; Magaña-Aquino M; Milán-Segovia RC; Portales-Pérez DP
    Mol Biol Rep; 2014 Dec; 41(12):7833-43. PubMed ID: 25163630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determining the relation between N-acetyltransferase-2 acetylator phenotype and antituberculosis drug induced hepatitis by molecular biologic tests.
    Bozok Cetintaş V; Erer OF; Kosova B; Ozdemir I; Topçuoğlu N; Aktoğu S; Eroğlu Z
    Tuberk Toraks; 2008; 56(1):81-6. PubMed ID: 18330759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis.
    Huang YS; Chern HD; Su WJ; Wu JC; Lai SL; Yang SY; Chang FY; Lee SD
    Hepatology; 2002 Apr; 35(4):883-9. PubMed ID: 11915035
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of polymorphic N-acetyl transferase2 and cytochrome P4502E1 gene in antituberculosis treatment-induced hepatitis.
    Bose PD; Sarma MP; Medhi S; Das BC; Husain SA; Kar P
    J Gastroenterol Hepatol; 2011 Feb; 26(2):312-8. PubMed ID: 21261721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-acetyltransferase and cytochrome P450 2E1 gene polymorphisms and susceptibility to antituberculosis drug hepatotoxicity in an Indian population.
    Mishra S; Daschakraborty S; Shukla P; Kapoor P; Aggarwal R
    Natl Med J India; 2013; 26(5):260-5. PubMed ID: 25017831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphic N-acetyltransferase (NAT2) in Amerindian populations of Panama and Colombia: high frequencies of point mutation 857A, as found in allele S3/M3.
    Arias TD; Jorge LF; Griese EU; Inaba T; Eichelbaum M
    Pharmacogenetics; 1993 Dec; 3(6):328-31. PubMed ID: 8148874
    [No Abstract]   [Full Text] [Related]  

  • 28. Genotype and allele frequencies of TPMT, NAT2, GST, SULT1A1 and MDR-1 in the Egyptian population.
    Hamdy SI; Hiratsuka M; Narahara K; Endo N; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
    Br J Clin Pharmacol; 2003 Jun; 55(6):560-9. PubMed ID: 12814450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arylamine N-acetyltransferase 2 gene polymorphism in an Algerian population.
    Chelouti H; Khelil M
    Ann Hum Biol; 2017 Sep; 44(6):531-536. PubMed ID: 28347189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Amino-3,8-dimethylimidazo-[4,5-f]quinoxaline-induced DNA adduct formation and mutagenesis in DNA repair-deficient Chinese hamster ovary cells expressing human cytochrome P4501A1 and rapid or slow acetylator N-acetyltransferase 2.
    Bendaly J; Zhao S; Neale JR; Metry KJ; Doll MA; States JC; Pierce WM; Hein DW
    Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1503-9. PubMed ID: 17627018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
    Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
    Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk.
    Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K
    Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatotoxicity during TB treatment in people with HIV/AIDS related to NAT2 polymorphisms in Pernambuco, Northeast Brazil.
    Araujo-Mariz C; Militão de Albuquerque MFP; Lopes EP; Ximenes RAA; Lacerda HR; Miranda-Filho DB; Lustosa-Martins BB; Pastor AFP; Acioli-Santos B
    Ann Hepatol; 2020; 19(2):153-160. PubMed ID: 31734174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards pharmacogenomics-guided tuberculosis (TB) therapy: N-acetyltransferase-2 genotypes among TB-infected Kenyans of mixed ethnicity.
    Njagi LN; Mecha JO; Mureithi MW; Otieno LE; Nduba V
    BMC Med Genomics; 2024 Jan; 17(1):14. PubMed ID: 38184575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study of NAT2 genetic polymorphism in West African subjects: example of an healthy non-smoker Senegalese population.
    Touré A; Diop C; Cabral M; Fall M; Lhermitte M; Diouf A; Broly F; Allorge D
    Mol Biol Rep; 2012 Dec; 39(12):10489-96. PubMed ID: 23053951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination and allelic allocation of seven nucleotide transitions within the arylamine N-acetyltransferase gene in the Polish population.
    Mrozikiewicz PM; Cascorbi I; Brockmöller J; Roots I
    Clin Pharmacol Ther; 1996 Apr; 59(4):376-82. PubMed ID: 8612380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of NAT2 genetic polymorphism with the efficacy of Neurotropin® for the enhancement of aggrecan gene expression in nucleus pulposus cells: a pilot study.
    Nakai T; Sakai D; Nakamura Y; Horikita N; Matsushita E; Naiki M; Watanabe M
    BMC Med Genomics; 2021 Mar; 14(1):79. PubMed ID: 33706752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cloning, sequencing, and recombinant expression of NAT1, NAT2, and NAT3 derived from the C3H/HeJ (rapid) and A/HeJ (slow) acetylator inbred mouse: functional characterization of the activation and deactivation of aromatic amine carcinogens.
    Fretland AJ; Doll MA; Gray K; Feng Y; Hein DW
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):360-6. PubMed ID: 9070359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene.
    Lin HJ; Han CY; Lin BK; Hardy S
    Pharmacogenetics; 1994 Jun; 4(3):125-34. PubMed ID: 7920692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.